APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
52 hedge funds and large institutions have $39M invested in Aptose Biosciences, Inc. in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Holders
52
Holding in Top 10
1
Calls
$269K
Puts
$25K
Top Buyers
| 1 | +$518K | |
| 2 | +$309K | |
| 3 | +$304K | |
| 4 |
AC
Annandale Capital
Dallas,
Texas
|
+$272K |
| 5 |
CC
Carlson Capital
Dallas,
Texas
|
+$224K |
Top Sellers
| 1 | -$2.73M | |
| 2 | -$624K | |
| 3 | -$472K | |
| 4 |
Millennium Management
New York
|
-$429K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$384K |